ArticleAnnals of the rheumatic diseases2020
Rare diseases 2030: how augmented AI will support diagnosis and treatment of rare diseases in the future.
Article in Annals of the rheumatic diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed.
- Accuracy and usability of a diagnostic decision support system in the diagnosis of three representative rheumatic diseases: a randomized controlled trial among medical students.Arthritis research & therapy · 2021Trial
- Multimodal natural language processing in ophthalmology: bridging clinical text and medical imaging.Frontiers in medicine · 2026Review
- SMOTE-augmented machine learning model predicts recurrent and metastatic breast cancer from microbiome analysis.Scientific reports · 2025Article
- Reliability of a generative artificial intelligence tool for pediatric familial Mediterranean fever: insights from a multicentre expert survey.Pediatric rheumatology online journal · 2024Article
- Does an App a Day Keep the Doctor Away? AI Symptom Checker Applications, Entrenched Bias, and Professional Responsibility.Journal of medical Internet research · 2024Article
- Citizen data sovereignty is key to wearables and wellness data reuse for the common good.NPJ digital medicine · 2024Article
- Patient Acceptability of Symptom Screening and Patient Education Using a Chatbot for Autoimmune Inflammatory Diseases: Survey Study.JMIR formative research · 2023Article
- [Faster diagnosis of rare diseases with artificial intelligence-A precept of ethics, economy and quality of life].Innere Medizin (Heidelberg, Germany) · 2023Review
- Rare diseases: why is a rapid referral to an expert center so important?BMC health services research · 2023Article
- [Acceptance of video consultation among patients with inflammatory rheumatic diseases depends on gender and location-Results of an online survey among patients and physicians].Zeitschrift fur Rheumatologie · 2023Article
- Integration of artificial intelligence and multi-omics in kidney diseases.Fundamental research · 2023Review
- Investigating the Potential for Clinical Decision Support in Sub-Saharan Africa With AFYA (Artificial Intelligence-Based Assessment of Health Symptoms in Tanzania): Protocol for a Prospective, Observational Pilot Study.JMIR research protocols · 2022Article
- COVID-19 and the rare disease organization response during pandemic: the 'Italian model'.Future rare diseases · 2022Article
- Artificial Intelligence in Medical Imaging and its Impact on the Rare Disease Community: Threats, Challenges and Opportunities.PET clinics · 2022Review
- Current Status of Genetic Counselling for Rare Diseases in Spain.Diagnostics (Basel, Switzerland) · 2021Review
- [What is confirmed in the diagnostics of autoinflammatory fever diseases?]Der Internist · 2021Review
- mEDUrare: Supporting Integrated Care for Rare Diseases by Better Connecting Health and Education Through Policy.The Yale journal of biology and medicine · 2021Review
- [Digital diagnostic support in rheumatology].Zeitschrift fur Rheumatologie · 2021Review
- Towards a Comprehensive Strategy for the Management of Rare Diseases in Slovenia: Outlining an IT-Enabled Ecosystemic Approach.International journal of environmental research and public health · 2021Article
- A Real-World Rheumatology Registry and Research Consortium: The German RheumaDatenRhePort (RHADAR) Registry.Journal of medical Internet research · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.